<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004952"><a href="http://purl.obolibrary.org/obo/MONDO_0004952">MONDO:0004952</a></h3>
<p><strong>Label:</strong> Hodgkins lymphoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009348">MONDO:0009348</a> (classic Hodgkin lymphoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_391">Orphanet:391</a>, <a href="http://purl.obolibrary.org/obo/OMIM_400021">OMIM:400021</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300221">OMIM:300221</a>, <a href="http://purl.obolibrary.org/obo/OMIM_236000">OMIM:236000</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0010702">HP:0010702</a> (Increased antibody level in blood) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003496">HP:0003496</a> (Increased IgM level) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003459">HP:0003459</a> (Polyclonal elevation of IgM) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000007">HP:0000007</a> (Autosomal recessive inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0003459">HP:0003459</a> (Polyclonal elevation of IgM) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003459">HP:0003459</a> (Polyclonal elevation of IgM) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system))) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0011017">HP:0011017</a> (Abnormality of cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0010702">HP:0010702</a> (Increased antibody level in blood) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0010701">HP:0010701</a> (Abnormal immunoglobulin level) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0005372">HP:0005372</a> (Abnormality of B cell physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0005368">HP:0005368</a> (Abnormality of humoral immunity) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0003496">HP:0003496</a> (Increased IgM level) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0003459">HP:0003459</a> (Polyclonal elevation of IgM) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002846">HP:0002846</a> (Abnormality of B cells) and <a href="http://purl.obolibrary.org/obo/HP_0003347">HP:0003347</a> (Impaired lymphocyte transformation with phytohemagglutinin) and <a href="http://purl.obolibrary.org/obo/HP_0012189">HP:0012189</a> (Hodgkin lymphoma) 62.50%</li>
</ul>
</body>
</html>
